- Home
- SLNH vs KROS Comparison
SLNH vs KROS Comparison
Compare SLNH & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SLNH | KROS |
|---|---|---|
| Founded | 1961 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 271.5M | 222.7M |
| IPO Year | 2005 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SLNH | KROS |
|---|---|---|
| Price | $0.59 | $11.10 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 7 |
| Target Price | $4.00 | ★ $19.83 |
| AVG Volume (30 Days) | ★ 7.0M | 161.9K |
| Earning Date | 11-16-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 80.41 | ★ 146.00 |
| EPS | ★ N/A | N/A |
| Revenue | $38,021,000.00 | ★ $243,864,000.00 |
| Revenue This Year | $107.79 | N/A |
| Revenue Next Year | $0.08 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 80.49 | N/A |
| 52 Week Low | $0.59 | $9.69 |
| 52 Week High | $4.04 | $22.55 |
Technical Indicators
Market Signals| Indicator | SLNH | KROS |
|---|---|---|
| Relative Strength Index (RSI) | 17.31 | 47.36 |
| Support Level | $0.59 | $10.70 |
| Resistance Level | $0.82 | $11.86 |
| Average True Range (ATR) | 0.07 | 0.51 |
| MACD | -0.04 | -0.08 |
| Stochastic Oscillator | 1.23 | 26.07 |
Price Performance
Historical ComparisonAbout SLNH Soluna Holdings Inc.
Soluna Holdings Inc is a U.S.-based company engaged in the development and operation of data centers powered by renewable energy. The company utilizes excess or curtailed energy from renewable sources to support high-performance computing applications, including cryptocurrency mining, artificial intelligence, and machine learning. Its business model focuses on converting underutilized renewable energy into computing resources through co-located data center infrastructure.
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.